Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

7.99
Delayed Data
As of Mar 31
 0.00 / 0.00%
Today’s Change
4.71
Today|||52-Week Range
9.24
+6.53%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$74.7M

Company Description

Imprimis Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the commercial development of novel drug formulations and proprietary drug delivery vehicles. It focuses on meeting unmet patient needs through the development and commercialization of innovative proprietary sterile and topical drug formulations and technologies that are customized for patients. Its network of innovators includes inventive physicians and pharmacists. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in San Diego, CA.

Contact Information

Imprimis Pharmaceuticals, Inc.
12626 High Bluff Drive
San Diego California 92130
P:(858) 704-4040
Investor Relations:
(858) 704-4587

Employees

Shareholders

Individual stakeholders29.66%
Other institutional15.89%
Mutual fund holders1.51%

Top Executives

Mark L. BaumChief Executive Office & Director
Andrew R. BollChief Financial Officer
John P. SaharekChief Commercial Officer
Gary W. SeelhorstVice President-Corporate Development
Jen Turbiak CarrollHead-Media Relations

To view my watchlist

Not a member yet?

Sign up now for a free account